Yorktown Management & Research Company’s Quest Diagnostics DGX Stock Holding History

Yorktown Management & Research Company’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,000	Closed	-$214K	–	258
2019 Q4	$214K	Hold	2,000	–	–	0.12%	266
2019 Q3	$214K	Sell	2,000 -3,000	-60%	-$308K	0.12%	271
2019 Q2	$509K	Hold	5,000	–	–	0.19%	141
2019 Q1	$450K	Buy	5,000 +2,000	+67%	+$173K	0.15%	168
2018 Q4	$250K	Buy	3,000 +400	+15%	+$37.5K	0.08%	277
2018 Q3	$281K	Buy	+2,600	New	+$285K	0.08%	308

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Yorktown Management & Research Company's DGX Position: Q1 2020 in Review

Yorktown Management & Research Company sold out of Quest Diagnostics (DGX) in Q1 2020, closing a stake of 2,000 shares — an estimated $214K sold.

Yorktown Management & Research Company first reported a position in DGX in Q3 2018 and held it in 6 quarters. The position peaked at $509K in Q2 2019. 715 funds tracked by Wall St. Rank hold DGX as of Q1 2020.

Yorktown Management & Research Company reported no remaining Quest Diagnostics position as of Q1 2020 after selling out during the quarter.
Yorktown Management & Research Company sold 2,000 Quest Diagnostics shares in Q1 2020, an estimated $214K.
Yorktown Management & Research Company first reported a position in Quest Diagnostics in Q3 2018 and held it in 6 quarters.
Yorktown Management & Research Company's Quest Diagnostics position peaked at $509K in Q2 2019.
715 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2020.

Based on Yorktown Management & Research Company's 13F filing for Q1 2020, filed 29 Apr 2020.